Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
BMC Cancer|June 5, 2015
TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patientsLoay Kassem, Mathieu Deygas, Laurent Fattet, et al.
Development (Cambridge, England)|November 17, 2012
Tif1γ is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibitionCédric Hesling, Jonathan Lopez, Laurent Fattet, et al.
Cancer Research|January 14, 2018
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10Adrien Nougarede, Nikolay Popgeorgiev, Loay Kassem, et al.
Neuroendocrinology|October 25, 2020
ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot StudyLaura Gerard, Jessica Garcia, Arnaud Gauthier, et al.
Nature Communications|March 5, 2024
Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO groupGilles Freyer, Anne Floquet, Olivier Tredan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinomaClaire Bournaud, Françoise Descotes, Myriam Decaussin-Petrucci, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic TumorsGaspard Jeremie, Fabienne Allias, Alexis Trecourt, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2025
ZEB1 transcription factor induces tumor cell PD-L1 expression in melanomaChloé Wirbel, Simon Durand, Félix Boivin, et al.
Pageof 11